Related Experiment Video
Updated: May 23, 2026
11:06
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
[Drug-induced liver injury]
Ludovico Abenavoli1, Emanuela Libri, Domenico Bosco
1Dipartmento di Scienze Della Salute, Università Magna Græcia, Catanzaro. l.abenavoli@unicz.it
Recenti Progressi in Medicina
|March 21, 2012
Summary
Drug-induced liver injury is a major cause of acute liver failure. Diagnosis is challenging due to the absence of specific biomarkers, and treatment is often ineffective, making drug cessation crucial.
Area of Science:
- Hepatology
- Toxicology
- Pharmacology
Background:
- Drug-induced liver injury (DILI) is a primary cause of acute liver failure and liver transplantation in Western countries.
- Numerous drugs and herbs are linked to liver injury, but underlying mechanisms remain unclear for most.
- Individuals consuming multiple medications face an elevated risk of developing DILI.
Purpose of the Study:
- To highlight the challenges in diagnosing and managing drug-induced liver injury.
- To emphasize the significance of identifying causative agents in DILI cases.
- To underscore the importance of prompt intervention in suspected DILI.
Main Methods:
- Review of existing literature on drug-induced liver injury.
- Analysis of diagnostic difficulties and therapeutic limitations.
- Discussion of clinical presentation and management strategies.
Main Results:
- DILI is a significant clinical problem with poorly understood mechanisms for many agents.
- Diagnosis is complicated by the lack of specific biomarkers and overlapping symptoms with other liver diseases.
- Effective therapeutic options for DILI are limited.
Conclusions:
- Early cessation of the suspected causative agent is the primary management step for drug-induced liver injury.
- Further research is needed to elucidate DILI mechanisms and develop targeted therapies.
- Improved diagnostic tools are essential for timely and accurate DILI identification.
Related Concept Videos
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:00Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...